Complete Response in Hairy Cell Leukemia to Anti-CD22 CAR T-Cell Therapy
Robert J. Kreitman(National Cancer Institute), Nirali N. Shah(National Institutes of Health), Lacey James(National Institutes of Health), Constance M. Yuan(National Cancer Institute), David Stroncek(National Institutes of Health), Mark Raffeld(National Cancer Institute), Liqiang Xi(Center for Cancer Research), Bonnie Yates(National Institutes of Health), Steve Highfill(National Institutes of Health), Katherine R. Calvo(National Institutes of Health Clinical Center), Brett Schroeder(National Cancer Institute), Ira Pastan(National Institutes of Health), Evrim Türkbey(National Institutes of Health Clinical Center), Evgeny Arons(National Institutes of Health), Hao‐Wei Wang(Fu Jen Catholic University), Hong Zhou(National Institutes of Health), M N Gould(National Institutes of Health), Stefania Pittaluga(New York University), Isaac Shpilman(National Institutes of Health), Olena Sierra Ortiz(National Institutes of Health)
Cited by 2
Related Papers
International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data
|Blood|2022|2.8k
Genetics and Pathogenesis of Diffuse Large B-Cell Lymphoma
|New England Journal of Medicine|2018|2.3k
Targeting B cell receptor signaling with ibrutinib in diffuse large B cell lymphoma
|Nature Medicine|2015|1.1k
Early-Onset Stroke and Vasculopathy Associated with Mutations in ADA2
|New England Journal of Medicine|2014|889